Associations of selenium status with cardiometabolic risk factors: An 8-year follow-up analysis of the Olivetti Heart Study

Atherosclerosis

Volumn 217, Issue 1, 2011, Pages 274-278

  Stranges, Saverio ^a   Galletti, Ferruccio ^b   Farinaro, Eduardo ^b   D'Elia, Lanfranco ^b   Russo, Ornella ^b   Iacone, Roberto ^b   Capasso, Clemente ^c   Carginale, Vincenzo ^c   De Luca, Viviana ^c   Della Valle, Elisabetta ^b   Cappuccio, Francesco P ^a   Strazzullo, Pasquale ^b  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c INSTITUTE OF PROTEIN BIOCHEMISTRY   (Italy)

Author keywords

Cardiometabolic risk; Cross sectional; Diabetes; Follow up; Lipids; Selenium

Indexed keywords

ANTILIPEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SELENIUM;

ADULT; AGE; AGED; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BLOOD LEVEL; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLISM; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

ADULT; AGED; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FOLLOW-UP STUDIES; HUMANS; ITALY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK FACTORS; SELENIUM; SPECTROPHOTOMETRY, ATOMIC;

EID: 79960203715     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.03.027     Document Type: Article

References (55)

1. Burk R.F. Selenium, an antioxidant nutrient. Nutr Clin Care 2002, 5:75-79.
2. Papp L.V., Lu J., Holmgren A., Khanna K.K. From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid Redox Signal 2007, 9:775-806.
3. Neve J. Selenium as a risk factor for cardiovascular diseases. J Cardiovasc Risk 1996, 3:42-44.
4. Combs G.F., Gray W.P. Chemopreventive agents: selenium. Pharmacol Ther 1998, 79:179-192.
5. Rayman M.P. The importance of selenium to human health. Lancet 2000, 356:233-241.
6. Salonen J.T., Alfthan G., Huttunen J.K., Pikkarainen J., Puska P. Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study. Lancet 1982, 2:175-179.
7. Virtamo J., Valkeila E., Alfthan G., et al. Serum selenium and the risk of coronary heart disease and stroke. Am J Epidemiol 1985, 122:276-282.
8. Blankenberg S., Rupprecht H.J., Bickel C., et al. Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med 2003, 349:1605-1613.
9. Wei W.Q., Abnet C.C., Qiao Y.L., et al. Prospective study of serum selenium concentrations and esophageal and gastric cardia cancer, heart disease, stroke, and total death. Am J Clin Nutr 2004, 79:80-85.
10. Flores-Mateo G., Navas-Acien A., Pastor-Barriuso R., et al. Selenium and coronary heart disease: a meta-analysis. Am J Clin Nutr 2006, 84:762-773.
11. Bleys J., Navas-Acien A., Guallar E. Serum selenium levels and all-cause, cancer, and cardiovascular mortality among US adults. Arch Intern Med 2008, 168:404-410.
12. Bleys J., Navas-Acien A., Laclaustra M., et al. Serum selenium and peripheral arterial disease: results from the National Health and Nutrition Examination Survey (NHANES) 2003-2004. Am J Epidemiol 2009, 169:996-1003.
13. Korpela H., Kumpulainen J., Jussila E., et al. Effect of selenium supplementation after acute myocardial infarction. Res Commun Chem Pathol Pharmacol 1989, 65:249-252.
14. Kuklinski B., Weissenbacher E., Fahnrich A. Coenzyme Q10 and antioxidants in acute myocardial infarction. Mol Aspects Med 1994, 15:S143-S147.
15. Stranges S., Marshall J.R., Trevisan M., et al. Effects of selenium supplementation on cardiovascular disease incidence and mortality: secondary analyses in a randomized clinical trial. Am J Epidemiol 2006, 163:694-699.
16. Bleys J., Navas-Acien A., Guallar E. Serum selenium and diabetes in U.S. adults. Diabetes Care 2007, 30:829-834.
17. Stranges S., Marshall J.R., Natarajan R., et al. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med 2007, 147:217-223.
18. Laclaustra M., Navas-Acien A., Stranges S., Ordovas J.M., Guallar E. Serum selenium concentrations and diabetes in US adults: National Health and Nutrition Examination Survey (NHANES) 2003-2004. Environ Health Perspect 2009, 117:1409-1413.
19. Stranges S., Sieri S., Vinceti M., et al. A prospective study of dietary selenium intake and risk of type 2 diabetes. BMC Public Health 2010, 10:564.
20. Bleys J., Navas-Acien A., Stranges S., et al. Serum selenium and serum lipids in US adults. Am J Clin Nutr 2008, 88:416-423.
21. Stranges S., Laclaustra M., Ji C., et al. Higher selenium status is associated with adverse blood lipid profile in British adults. J Nutr 2010, 140:81-87.
22. Laclaustra M., Stranges S., Navas-Acien A., Ordovas J.M., Guallar E. Serum selenium and plasma lipids in US adults: National Health and Nutrition Examination Survey (NHANES) 2003-2004. Atherosclerosis 2010, 210:643-648.
23. Laclaustra M., Navas-Acien A., Stranges S., Ordovas J.M., Guallar E. Serum selenium levels and hypertension in the US population. Circ Cardiovasc Qual Outcomes 2009, 2:369-376.
24. Cappuccio F.P., Strazzullo P., Farinaro E., Trevisan M. Uric acid metabolism and tubular sodium handling: results from a population based study. JAMA 1993, 270:354-359.
25. Galletti F., Barbato A., Versiero M., et al. Circulating leptin levels predict the development of metabolic syndrome in middle-aged men: an 8-year follow-up study. J Hypertens 2007, 25:1671-1677.
26. Galletti F., D'Elia L., Barba G., et al. High-circulating leptin levels are associated with greater risk of hypertension in men independently of body mass and insulin resistance: results of an eight-year follow-up study. J Clin Endocrinol Metab 2008, 93:3922-3926.
27. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
28. Morisi G., Patriarca M., Marano G., et al. Age and sex specific reference serum selenium levels estimated for the Italian population. Ann Ist Super Sanita 1989, 25:393-404.
29. Jossa F., Trevisan M., Krogh V., et al. Serum selenium and coronary heart disease risk factors in southern Italian men. Atherosclerosis 1991, 87:129-134.
30. Sesana G., Baj A., Toffoletto F., et al. Plasma selenium levels of the general population of an area in northern Italy. Sci Total Environ 1992, 120:97-102.
31. Ringstad J., Jacobsen B.K., Thomassen Y. The Tromso Heart Study: relationships between the concentration of selenium in serum and risk factors for coronary heart disease. J Trace Elem Electrolytes Health Dis 1987, 1:27-31.
32. Suadicani P., Hein H.O., Gyntelberg F. Serum selenium concentration and risk of ischaemic heart disease in a prospective cohort study of 3000 males. Atherosclerosis 1992, 96:33-42.
33. Gamez C., Ruiz-Lopez D., Artacho R., et al. Serum selenium in institutionalized elderly subjects and relation to other nutritional markers. Clin Chem 1997, 43:693-694.
34. Berr C., Coudray C., Bonithon-Kopp C., et al. Demographic and cardiovascular risk factors in relation to antioxidant status: the EVA Study. Int J Vitam Nutr Res 1998, 68:26-35.
35. Yang K.C., Lee L.T., Lee Y.S., et al. Serum selenium concentration is associated with metabolic factors in the elderly: a cross-sectional study. Nutr Metab 2010, 7:38.
36. Luoma P.V., Sotaniemi E.A., Korpela H., Kumpulainen J. Serum selenium, glutathione peroxidase activity and high-density lipoprotein cholesterol - effect of selenium supplementation. Res Commun Chem Pathol Pharmacol 1984, 46:469-472.
37. Yu S.Y., Mao B.L., Xiao P., et al. Intervention trial with selenium for the prevention of lung cancer among tin miners in Yunnan, China. A pilot study. Biol Trace Elem Res 1990, 24:105-108.
38. Rayman MP, Stranges S, Griffin B, Pastor-Barriuso R, Guallar E. Effect of supplementation with high-selenium yeast on plasma lipids: a randomized, controlled trial. Ann Intern Med 2011; in press.
39. Salonen J.T., Salonen R., Seppanen K., et al. Relationship of serum selenium and antioxidants to plasma lipoproteins, platelet aggregability and prevalent ischaemic heart disease in Eastern Finnish men. Atherosclerosis 1988, 70:155-160.
40. Virtamo J., Valkeila E., Alfthan G., et al. Serum selenium and the risk of coronary heart-disease and stroke. Am J Epidemiol 1985, 122:276-282.
41. Nawrot T.S., Staessen J.A., Roels H.A., et al. Blood pressure and blood selenium: a cross-sectional and longitudinal population study. Eur Heart J 2007, 28:628-633.
42. Burk R.F., Hill K.E., Olson G.E., et al. Deletion of apolipoprotein E receptor-2 in mice lowers brain selenium and causes severe neurological dysfunction and death when a low-selenium diet is fed. J Neurosci 2007, 27:6207-6211.
43. Valentine W.M., Abel T.W., Hill K.E., Austin L.M., Burk R.F. Neurodegeneration in mice resulting from loss of functional selenoprotein P or its receptor apolipoprotein E receptor 2. J Neuropathol Exp Neurol 2008, 67:68-77.
44. Olson G.E., Winfrey V.P., Hill K.E., Burk R.F. Megalin mediates selenoprotein P uptake by kidney proximal tubule epithelial cells. J Biol Chem 2008, 283:6854-6860.
45. Burk R.F., Hill K.E. Selenoprotein P - expression, functions, and roles in mammals. Biochim Biophys Acta 2009, 1790:1441-1447.
46. Misu H., Takamura T., Takayama H., et al. A liver-derived secretory protein, selenoprotein P, causes insulin resistance. Cell Metab 2010, 12:483-495.
47. Whanger P., Vendeland S., Park Y.C., Xia Y. Metabolism of sub-toxic levels of selenium in animals and humans. Ann Clin Lab Sci 1996, 26:99-113.
48. Food and Nutrition Board, Institute of Medicine Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. A report of the Panel on Dietary Antioxidants and Related Compounds, Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Uses of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes 2000, National Academy Press, Washington, DC.
49. Duffield A.J., Thomson C.D., Hill K.E., et al. An estimation of selenium requirements for New Zealanders. Am J Clin Nutr 1999, 70:896-903.
50. Rayman M.P. Food-chain selenium and human health: emphasis on intake. Br J Nutr 2008, 100:254-268.
51. Navas-Acien A., Bleys J., Guallar E. Selenium intake and cardiovascular risk - what is new?. Curr Opin Lipidol 2008, 19:43-49.
52. Rayman M.P. Selenoproteins and human health: insights from epidemiological data. Biochim Biophys Acta 2009, 1790:1533-1540.
53. Mueller A.S., Mueller K., Wolf N.M., Pallauf J. Selenium and diabetes: an enigma?. Free Radic Res 2009, 43:1029-1059.
54. Gore F., Fawell J., Bartram J. Too much or too little? A review of the conundrum of selenium. J Water Health 2010, 8:405-416.
55. Stranges S., Navas-Acien A., Rayman M.P., Guallar E. Selenium status and cardio-metabolic health: state of the evidence. Nutr Metab Cardiovasc Dis 2010, 20:754-760.